Maxigen Biotech Inc (1783) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.13x

Maxigen Biotech Inc (1783) has a Cash Flow Reinvestment Rate of 0.13x as of March 2026, reinvesting NT$10.47 Million (capex NT$10.47 Million ) from operating cash flow of NT$79.84 Million. Explore 1783 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.13x
(Capex + Investments) / Operating CF

Total Reinvested

NT$10.47 Million
Capex + Investments

Operating Cash Flow

NT$79.84 Million
TWD

Capital Expenditures

NT$10.47 Million
TWD

Maxigen Biotech Inc Cash Flow Reinvestment Rate (2009–2025)

Historical reinvestment intensity for Maxigen Biotech Inc across 12 annual periods. Also explore 1783 asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Maxigen Biotech Inc (2009–2025)

Year-by-year capital reinvestment analysis for Maxigen Biotech Inc. For live market cap and broader valuation context, see Maxigen Biotech Inc market cap and net worth.

Year Reinvestment Rate Total Reinvested (TWD) Operating CF Capex YoY Change
2025 1.32x NT$382.63 Million NT$290.22 Million NT$82.63 Million ▲ +1137.5%
2024 0.11x NT$31.77 Million NT$298.22 Million NT$31.77 Million ▼ -96.4%
2023 2.99x NT$512.69 Million NT$171.20 Million NT$22.44 Million ▲ +2492.4%
2022 0.12x NT$31.00 Million NT$268.34 Million NT$14.44 Million ▼ -53.5%
2021 0.25x NT$29.19 Million NT$117.59 Million NT$15.45 Million ▼ -88.7%
2020 2.19x NT$163.26 Million NT$74.39 Million NT$11.34 Million ▲ +127.8%
2019 0.96x NT$90.94 Million NT$94.42 Million NT$23.74 Million ▲ +26.9%
2018 0.76x NT$129.43 Million NT$170.58 Million NT$20.23 Million ▼ -71.0%
2017 2.61x NT$107.57 Million NT$41.18 Million NT$29.01 Million ▼ -57.7%
2016 6.18x NT$214.54 Million NT$34.72 Million NT$72.71 Million ▲ +1634.5%
2012 0.36x NT$6.24 Million NT$17.53 Million NT$6.24 Million ▼ -9.9%
2009 0.40x NT$7.62 Million NT$19.27 Million NT$7.62 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow